Hartline Investment Corp’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-32,097
| Closed | -$503K | – | 116 |
|
2019
Q1 | $503K | Buy |
32,097
+125
| +0.4% | +$1.96K | 0.13% | 86 |
|
2018
Q4 | $493K | Sell |
31,972
-150
| -0.5% | -$2.31K | 0.15% | 83 |
|
2018
Q3 | $692K | Sell |
32,122
-125
| -0.4% | -$2.69K | 0.16% | 81 |
|
2018
Q2 | $784K | Sell |
32,247
-1,785
| -5% | -$43.4K | 0.21% | 69 |
|
2018
Q1 | $582K | Sell |
34,032
-470
| -1% | -$8.04K | 0.16% | 80 |
|
2017
Q4 | $654K | Sell |
34,502
-3,001
| -8% | -$56.9K | 0.18% | 80 |
|
2017
Q3 | $660K | Hold |
37,503
| – | – | 0.2% | 79 |
|
2017
Q2 | $1.25M | Buy |
37,503
+200
| +0.5% | +$6.65K | 0.4% | 58 |
|
2017
Q1 | $1.2M | Sell |
37,303
-345
| -0.9% | -$11.1K | 0.39% | 61 |
|
2016
Q4 | $1.37M | Sell |
37,648
-1,125
| -3% | -$40.8K | 0.48% | 54 |
|
2016
Q3 | $1.78M | Sell |
38,773
-39
| -0.1% | -$1.79K | 0.64% | 41 |
|
2016
Q2 | $1.95M | Sell |
38,812
-20
| -0.1% | -$1.01K | 0.7% | 36 |
|
2016
Q1 | $2.08M | Hold |
38,832
| – | – | 0.76% | 34 |
|
2015
Q4 | $2.55M | Buy |
38,832
+6,169
| +19% | +$405K | 0.95% | 29 |
|
2015
Q3 | $1.84M | Sell |
32,663
-7,694
| -19% | -$434K | 0.67% | 35 |
|
2015
Q2 | $2.39M | Sell |
40,357
-266
| -0.7% | -$15.7K | 0.79% | 41 |
|
2015
Q1 | $2.53M | Sell |
40,623
-89
| -0.2% | -$5.55K | 0.83% | 38 |
|
2014
Q4 | $2.34M | Hold |
40,712
| – | – | 0.78% | 39 |
|
2014
Q3 | $2.19M | Sell |
40,712
-55
| -0.1% | -$2.96K | 0.79% | 41 |
|
2014
Q2 | $2.14M | Sell |
40,767
-30
| -0.1% | -$1.57K | 0.77% | 43 |
|
2014
Q1 | $2.16M | Buy |
40,797
+120
| +0.3% | +$6.34K | 0.74% | 48 |
|
2013
Q4 | $1.63M | Hold |
40,677
| – | – | 0.57% | 54 |
|
2013
Q3 | $1.54M | Hold |
40,677
| – | – | 0.6% | 53 |
|
2013
Q2 | $1.6M | Buy |
+40,677
| New | +$1.6M | 0.64% | 51 |
|